Jackie Thorne
@jackiethorne007
X Philanthropy @Pulte, @TeamPulte
$AMC $GME $PHM
#BeKind #HelpOneAnother
ID: 1937107076
05-10-2013 09:39:28
1,1K Tweet
559 Takipçi
829 Takip Edilen
While the world embraces NK therapy created in the United States, our U.S. FDA puts up road blocks for cancer patients. Unleash #ANKTIVA Robert F. Kennedy Jr Dr. Marty Makary
$IBRX - While the FDA fast-tracks another "warp speed" lung cancer drug in 44 days, Anktiva—proven superior in trials—languishes. No media frenzy? Maybe because it's a game-changer that threatens Big Pharma's status quo. Time to approve the best! #Anktiva #BioShield Dr. Pat Soon-Shiong
$IBRX This is amazing and promising. Great work by Dr. Pat Soon-Shiong Simultaneously, it’s infuriating. The FDA needs to wake up. President Donald J. Trump Secretary Kennedy Robert F. Kennedy Jr Marty Makary MD, MPH Dr. Marty Makary There’s no logical reason why ANKTIVA shouldn’t be available to all tumor types and other
$IBRX Dr. Karen Knudsen, CEO of the Parker Institute for Cancer Immunotherapy, joined Cuomo last night, together with Dr. Pat Soon-Shiong “I agree that the immune system and immunology is how we are going to cure cancer.” “Those therapies that are driving down now the mortality rates
Met Jay Bhattacharya who heads NIH and Anthony Letai MD PhD who heads NCI for the first time. The joy of a deep conversation between true scientists and doctors whose life’s mission is to help our patients and the American people is evident! I truly enjoyed discussing the science